Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease
- 15 July 2005
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 172 (2), 195-199
- https://doi.org/10.1164/rccm.200412-1747oc
Abstract
Moraxella catarrhalis is frequently present in the sputum of adults with chronic obstructive pulmonary disease (COPD). Little is known about the role of M. catarrhalis in this common disease. To elucidate the burden of disease, the dynamics of carriage, and immune responses to M. catarrhalis in COPD. Prospective cohort study of 104 adults with COPD in an outpatient clinic at the Buffalo Veterans Affairs Medical Center. Clinical information, sputum cultures, molecular typing of isolates, and immunoassays to measure antibodies to M. catarrhalis. Over 81 months, 104 patients made 3,009 clinic visits, 560 during exacerbations. Molecular typing identified 120 episodes of acquisition and clearance of M. catarrhalis in 50 patients; 57 (47.5%) of the acquisitions were associated with clinical exacerbations. No instances of simultaneous acquisition of a new strain of another pathogen were observed. The duration of carriage of M. catarrhalis was shorter with exacerbations compared with asymptomatic colonization (median, 31.0 vs. 40.4 days; p = 0.01). Reacquisition of the same strain was rare. The intensity of the serum IgG response was greater after exacerbations than asymptomatic colonization (p = 0.009). Asymptomatic colonization was associated with a greater frequency of a sputum IgA response than exacerbation (p = 0.009). M. catarrhalis likely causes approximately 10% of exacerbations of COPD, accounting for approximately 2 to 4 million episodes annually. The organism is cleared efficiently after a short duration of carriage. Patients develop strain-specific protection after clearance of M. catarrhalis from the respiratory tract.This publication has 28 references indexed in Scilit:
- Systemic and Mucosal Antibody Response toMoraxella catarrhalisafter Exacerbations of Chronic Obstructive Pulmonary DiseaseThe Journal of Infectious Diseases, 2002
- Sequence Stability of the Gene Encoding Outer Membrane Protein P2 of NontypeableHaemophilus influenzaein the Human Respiratory TractThe Journal of Infectious Diseases, 2002
- Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art ReviewClinical Microbiology Reviews, 2001
- Impact of Antimicrobial Therapy on Nasopharyngeal Carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in Children with Respiratory Tract InfectionsClinical Infectious Diseases, 2000
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Incidence of Branhamella catarrhalis in the Sputa of Patients with Chronic Lung DiseaseDrugs, 1986
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982
- A study of infective and other factors in exacerbations of chronic bronchitisRespiratory Medicine, 1980
- SPUTUM IN CHRONIC BRONCHITIS EFFECTS OF ANTIBIOTICSThe Lancet, 1953
- THE BACTERIOLOGY OF CHRONIC BRONCHITISThe Lancet, 1953